AXGT Sio Gene Therapies, Inc

USD 2.56 0.00 0
Icon

Sio Gene Therapies, Inc (AXGT) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.56

0.00 (0.00)%

USD 0.10B

1.54M

N/A

N/A

Icon

AXGT

Sio Gene Therapies, Inc (USD)
COMMON STOCK | NSD
USD 2.56
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.10B

N/A

USD 2.56

Sio Gene Therapies, Inc (AXGT) Stock Forecast

N/A

Based on the Sio Gene Therapies, Inc stock forecast from 0 analysts, the average analyst target price for Sio Gene Therapies, Inc is not available over the next 12 months. Sio Gene Therapies, Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Sio Gene Therapies, Inc is Very Bearish, which is based on 0 positive signals and 1 negative signals. At the last closing, Sio Gene Therapies, Inc’s stock price was USD 2.56. Sio Gene Therapies, Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Sio Gene Therapies, Inc
No recent average analyst rating found for Sio Gene Therapies, Inc

Company Overview Sio Gene Therapies, Inc

Axovant Gene Therapies Ltd., a clinical-stage gene therapy company, focuses on developing various product candidates for debilitating neurodegenerative diseases. The company's clinical-stage programs include AXO-Lenti-PD program for the treatment of Parkinson's disease; AXO-AAV-G...Read More

http://www.axovant.com

11-12 St. James's Square, London, United Kingdom, SW1Y 4LB

38

March

USD

USA

Adjusted Closing Price for Sio Gene Therapies, Inc (AXGT)

Loading...

Unadjusted Closing Price for Sio Gene Therapies, Inc (AXGT)

Loading...

Share Trading Volume for Sio Gene Therapies, Inc Shares

Loading...

Compare Performance of Sio Gene Therapies, Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AXGT

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Sio Gene Therapies, Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD90.24B 26.31 16.84

ETFs Containing AXGT

Symbol Name AXGT's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Sio Gene Therapies, Inc (AXGT) Stock

Stock Target Advisor's fundamental analysis for Sio Gene Therapies, Inc's stock is Very Bearish.

Unfortunately we do not have enough data on AXGT's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on AXGT's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on AXGT's stock to indicate if its overvalued.

The last closing price of AXGT's stock was USD 2.56.

The most recent market capitalization for AXGT is USD 0.10B.

Unfortunately we do not have enough analyst data on AXGT's stock to indicate whether its price will go up or not.

A PHP Error was encountered

Severity: Warning

Message: Undefined variable $etfs_link

Filename: stock-details/faqs.php

Line Number: 256

Backtrace:

File: /var/www/html/stocktarget/application/views/stock-details/faqs.php
Line: 256
Function: _error_handler

File: /var/www/html/stocktarget/application/views/stock-details/stock-detailss.php
Line: 2400
Function: include

File: /var/www/html/stocktarget/application/controllers/Stock_details.php
Line: 853
Function: view

File: /var/www/html/stocktarget/index.php
Line: 322
Function: require_once

We can't find any ETFs which contains Sio Gene Therapies, Inc's stock.

As per our most recent records Sio Gene Therapies, Inc has 38 Employees.

Sio Gene Therapies, Inc's registered address is 11-12 St. James's Square, London, United Kingdom, SW1Y 4LB. You can get more information about it from Sio Gene Therapies, Inc's website at http://www.axovant.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...